G1 Therapeutics Inc (NAS:GTHX)
$ 7.15 0 (0%) Market Cap: 377.22 Mil Enterprise Value: 364.45 Mil PE Ratio: 0 PB Ratio: 15.31 GF Score: 34/100

G1 Therapeutics Inc Commercial update Call Transcript

Dec 16, 2021 / 01:30PM GMT
Release Date Price: $10.16 (-4.78%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the G1 commercial update. (Operator Instructions) I would now like to turn the call over to your host, Will Roberts, you may begin.

William C. Roberts
G1 Therapeutics, Inc. - VP of IR & Corporate Communications

Thank you, Kevin. Good morning, everyone, and welcome to the G1 conference call to discuss the expansion of our COSELA sales force and the mutual agreement with Boehringer Ingelheim to end our co-promotion agreement.

The press release was issued this morning and can be found in the news section of our corporate website www.g1therapeutics.com. And as Kevin mentioned, a Q&A session will follow the prepared comments.

Before we begin, I want to remind you today that today's webcast contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements represent management's judgment as of today and may involve risks and uncertainties that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot